DrugPatentWatch Database Preview
Details for Patent: 8,524,773
Which drugs does patent 8,524,773 protect, and when does it expire?
Patent 8,524,773 protects TECFIDERA and is included in one NDA.
This patent has forty-seven patent family members in thirty-one countries.
This patent has forty-seven patent family members in thirty-one countries.
Summary for Patent: 8,524,773
| Title: | Utilization of dialkylfumarates |
| Abstract: | The present invention relates to the use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets. For this purpose, the dialkyl fumarates may also be used in combination with conventional preparations used in transplantation medicine and immunosuppressive agents, especially cyclosporines. |
| Inventor(s): | Joshi; Rajendra Kumar (Zurich, CH), Strebel; Hans-Peter (Muri, CH) |
| Assignee: | Biogen Idec International GmbH (Zug, CH) |
| Application Number: | 13/612,221 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 8,524,773
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biogen Idec Inc | TECFIDERA | dimethyl fumarate | CAPSULE, DELAYED RELEASE;ORAL | 204063-001 | Mar 27, 2013 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | METHOD OF TREATING MULTIPLE SCLEROSIS | ➤ Sign Up | ||||
| Biogen Idec Inc | TECFIDERA | dimethyl fumarate | CAPSULE, DELAYED RELEASE;ORAL | 204063-002 | Mar 27, 2013 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | METHOD OF TREATING MULTIPLE SCLEROSIS | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
Foreign Priority and PCT Information for Patent: 8,524,773
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Germany | 198 53 487 | Nov 19, 1998 |
Non-Orange Book US Patents Family Members for Patent 8,524,773
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 7,619,001 | Utilization of dialkylfumarates | ➤ Sign Up |
| 7,915,310 | Utilization of dialkylfumarates | ➤ Sign Up |
| 8,759,393 | Utilization of dialkylfumarates | ➤ Sign Up |
| 6,509,376 | Utilization of dialkyfumarates | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Family Members for US Patent 8,524,773
| Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Turkey | 200101204 | ➤ Sign Up | |||
| Slovakia | 285601 | ➤ Sign Up | |||
| Slovakia | 5762001 | ➤ Sign Up | |||
| Slovenia | 1131065 | ➤ Sign Up | |||
| Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
